Twiist automated insulin delivery system FDA cleared for children 6 years and up with T1D
March 18th 2024Integrated data from a continuous glucose monitoring device (CGM) and an insulin pump to automate insulin delivery allow AID systems to manage patient blood sugar levels more "effectively," according to Sequel.
Synthesizing CDC immunization recommendations with Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
March 16th 2024Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, provided a review and reminder of the CDC immunization recommendations and schedule during her session at the 45th National Association of Pediatric Nurse Practitioners (NAPNAP) National Conference on Pediatric Health Care in Denver, Colorado.
Mothers with high BMI less likely to breastfeed
March 15th 2024Mothers who are overweight or obese are more likely to breastfeed for shorter durations or not breastfeed at all when compared to mothers of normal weight, according to new research presented in a poster session at the NAPNAP 2024 National Conference on Pediatric Health Care in Denver, Colorado.
NAPNAP networking opportunities, navigating artificial intelligence in health care
March 14th 2024Tracie W. Kirkland, PhD, DNP, ANP-BC, PPCPNP, CPNP-BC, shares why she looks forward to networking at the 2024 NAPNAP National Conference on Pediatric Health Care, taking place from March 13-16, 2024, in Denver, Colorado.
Sessions and topics to look forward to at the 2024 NAPNAP National Conference
March 13th 2024Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, shares her thoughts and excitement for the 2024 NANAP National Conference on Pediatric Health Care, taking place in Denver, Colorado, from March 13-16, 2024.
Medical spending for children with mental health conditions increased 31% from 2017-2021
March 12th 2024In 2021, pediatric mental health conditions were associated with $31 billion in child spending and $59 billion in household spending, which made up 46.6% of all pediatric medical spending that year.
FDA approves alirocumab to treat HeFH patients aged 8 years and up
March 12th 2024The approval is based on data from a phase 3, multicenter, randomized trial that evaluated patients aged 8 to 17 years with HeFH who had LDL-C levels of 130 mg / dL or greater who were being treated with lipid-lowering medications.
Addressing the mental health needs of sexual- and gender-diverse youth
March 11th 2024Research has demonstrated that SGDY exhibit significantly elevated incidence of mental health diagnoses and conditions compared with their counterparts, including higher rates of suicidality, depressive and anxiety disorders, and substance misuse.
Navigating the current shortages of pediatric ADHD medications
Understand how to naviate the current shortage of pediatric ADHD medications.
Tapinarof cream 1% demonstrates efficacy in atopic dermatitis patients with skin of color
March 8th 2024Data from a pair of identical, phase 3, double-blind, randomized, and vehicle-controlled trials were presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California.